Richtlijn HIV
Deze pagina is het laatst bewerkt op 28 apr 2021 om 12:32. | Deze pagina is 35.792 maal bekeken.

Lijst met verwijzingen naar andere richtlijnen

Uit Richtlijnen HIV

(Verschil tussen bewerkingen)
Ga naar: navigatie, zoeken
(Nieuwe pagina aangemaakt met 'In onderstaande tabel staan verwijzingen naar andere richtlijnen opgesomd: <html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:off…')
(45 tussenliggende versies worden niet weergegeven)
Regel 1: Regel 1:
-
In onderstaande tabel staan verwijzingen naar andere richtlijnen opgesomd:
+
In onderstaande tabel staan per hoofdstuk/paragraaf verwijzingen naar andere richtlijnen vermeld:<br>
-
<html xmlns:v="urn:schemas-microsoft-com:vml"
+
{| width="100%" border="1" align="left" cellspacing="1" cellpadding="1"
-
xmlns:o="urn:schemas-microsoft-com:office:office"
+
|-
-
xmlns:w="urn:schemas-microsoft-com:office:word"
+
| valign="top" align="left" | '''Pagina'''<br>  
-
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
+
| width="45" valign="top" align="left" | '''Link naar andere richtlijn'''
-
xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=windows-1252"><meta name=ProgId content=Word.Document><meta name=Generator content="Microsoft Word 14"><meta name=Originator content="Microsoft Word 14"><link rel=File-List
+
|-
-
href="Tabel%20verwijzing%20andere%20richtlijnen_bestanden/filelist.xml"><&#33;--[if gte mso 9]><xml><o:DocumentProperties><o:Author>Mariska Tuut</o:Author><o:LastAuthor>Mariska Tuut</o:LastAuthor><o:Revision>1</o:Revision><o:TotalTime>24</o:TotalTime><o:Created>2011-12-09T13:52:00Z</o:Created><o:LastSaved>2011-12-09T14:16:00Z</o:LastSaved><o:Pages>3</o:Pages><o:Words>2123</o:Words><o:Characters>11680</o:Characters><o:Lines>97</o:Lines><o:Paragraphs>27</o:Paragraphs><o:CharactersWithSpaces>13776</o:CharactersWithSpaces><o:Version>14.00</o:Version></o:DocumentProperties><o:OfficeDocumentSettings><o:AllowPNG/></o:OfficeDocumentSettings></xml><&#33;[endif]--><link rel=themeData
+
| valign="top" align="left" | [[Inhoud|'''Inhoud''']]
-
href="Tabel%20verwijzing%20andere%20richtlijnen_bestanden/themedata.thmx"><link rel=colorSchemeMapping
+
| width="45" valign="top" align="left" | SOA richtlijn<br>PrEP richtlijn
-
href="Tabel%20verwijzing%20andere%20richtlijnen_bestanden/colorschememapping.xml"><&#33;--[if gte mso 9]><xml><w:WordDocument><w:SpellingState>Clean</w:SpellingState><w:GrammarState>Clean</w:GrammarState><w:TrackMoves>false</w:TrackMoves><w:TrackFormatting/><w:HyphenationZone>21</w:HyphenationZone><w:PunctuationKerning/><w:ValidateAgainstSchemas/><w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid><w:IgnoreMixedContent>false</w:IgnoreMixedContent><w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText><w:DoNotPromoteQF/><w:LidThemeOther>NL</w:LidThemeOther><w:LidThemeAsian>X-NONE</w:LidThemeAsian><w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript><w:Compatibility><w:BreakWrappedTables/><w:SnapToGridInCell/><w:WrapTextWithPunct/><w:UseAsianBreakRules/><w:DontGrowAutofit/><w:SplitPgBreakAndParaMark/><w:EnableOpenTypeKerning/><w:DontFlipMirrorIndents/><w:OverrideTableStyleHps/></w:Compatibility><m:mathPr><m:mathFont m:val="Cambria Math"/><m:brkBin m:val="before"/><m:brkBinSub m:val="&#45;-"/><m:smallFrac m:val="off"/><m:dispDef/><m:lMargin m:val="0"/><m:rMargin m:val="0"/><m:defJc m:val="centerGroup"/><m:wrapIndent m:val="1440"/><m:intLim m:val="subSup"/><m:naryLim m:val="undOvr"/></m:mathPr></w:WordDocument></xml><&#33;[endif]--><&#33;--[if gte mso 9]><xml><w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
+
|-
-
DefSemiHidden="true" DefQFormat="false" DefPriority="99"
+
| valign="top" align="left" | '''[[Hoofdstuk 2. Therapie bij volwassenen]]<br>'''
-
LatentStyleCount="267"><w:LsdException Locked="false" Priority="0" SemiHidden="false"
+
| width="45" valign="top" align="left" | <br>
-
UnhideWhenUsed="false" QFormat="true" Name="Normal"/><w:LsdException Locked="false" Priority="9" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" QFormat="true" Name="heading 1"/><w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/><w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/><w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/><w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/><w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/><w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/><w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/><w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/><w:LsdException Locked="false" Priority="39" Name="toc 1"/><w:LsdException Locked="false" Priority="39" Name="toc 2"/><w:LsdException Locked="false" Priority="39" Name="toc 3"/><w:LsdException Locked="false" Priority="39" Name="toc 4"/><w:LsdException Locked="false" Priority="39" Name="toc 5"/><w:LsdException Locked="false" Priority="39" Name="toc 6"/><w:LsdException Locked="false" Priority="39" Name="toc 7"/><w:LsdException Locked="false" Priority="39" Name="toc 8"/><w:LsdException Locked="false" Priority="39" Name="toc 9"/><w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/><w:LsdException Locked="false" Priority="10" SemiHidden="false"
+
| valign="top" align="left" | [[2.1. Wanneer beginnen?]] <br>  
-
UnhideWhenUsed="false" QFormat="true" Name="Title"/><w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/><w:LsdException Locked="false" Priority="11" SemiHidden="false"
+
| width="45" valign="top" align="left" | Aidsinfo NIH
-
UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/><w:LsdException Locked="false" Priority="22" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" QFormat="true" Name="Strong"/><w:LsdException Locked="false" Priority="20" SemiHidden="false"
+
| valign="top" align="left" | [[2.2. Keuze van antiretrovirale therapie bij naïeve volwassenen met hiv|2.2. Keuze van anti-retrovirale therapie bij naïeve volwassenen met hiv]]<br>  
-
UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/><w:LsdException Locked="false" Priority="59" SemiHidden="false"
+
| width="45" valign="top" align="left" | Aidsinfo NIH
-
UnhideWhenUsed="false" Name="Table Grid"/><w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/><w:LsdException Locked="false" Priority="1" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/><w:LsdException Locked="false" Priority="60" SemiHidden="false"
+
| valign="top" align="left" | [[2.3. Tijdelijk onderbreken van antiretrovirale therapie|2.3. Tijdelijk onderbreken van anti-retrovirale therapie]]<br>  
-
UnhideWhenUsed="false" Name="Light Shading"/><w:LsdException Locked="false" Priority="61" SemiHidden="false"
+
| width="45" valign="top" align="left" | Aidsinfo NIH
-
UnhideWhenUsed="false" Name="Light List"/><w:LsdException Locked="false" Priority="62" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Light Grid"/><w:LsdException Locked="false" Priority="63" SemiHidden="false"
+
| valign="top" align="left" | [[2.4. Richtlijn anti-retrovirale therapie bij voorbehandelde mensen met hiv|2.4. Richtlijn anti-retrovirale therapie bij voorbehandelde mensen met hiv]]<br>  
-
UnhideWhenUsed="false" Name="Medium Shading 1"/><w:LsdException Locked="false" Priority="64" SemiHidden="false"
+
| width="45" valign="top" align="left" | Aidsinfo NIH
-
UnhideWhenUsed="false" Name="Medium Shading 2"/><w:LsdException Locked="false" Priority="65" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Medium List 1"/><w:LsdException Locked="false" Priority="66" SemiHidden="false"
+
| valign="top" align="left" | '''[[Hoofdstuk 3. Behandeling van hiv-1 infectie bij kinderen|Hoofdstuk 3. Behandeling van hiv-1 infectie bij kinderen]]'''
-
UnhideWhenUsed="false" Name="Medium List 2"/><w:LsdException Locked="false" Priority="67" SemiHidden="false"
+
| width="45" valign="top" align="left" | Aidsinfo NIH<br>Kinderformularium
-
UnhideWhenUsed="false" Name="Medium Grid 1"/><w:LsdException Locked="false" Priority="68" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Medium Grid 2"/><w:LsdException Locked="false" Priority="69" SemiHidden="false"
+
| valign="top" align="left" | '''[[Hoofdstuk 4. Monitoring]]<br>'''  
-
UnhideWhenUsed="false" Name="Medium Grid 3"/><w:LsdException Locked="false" Priority="70" SemiHidden="false"
+
| width="45" valign="top" align="left" | Aidsinfo NIH
-
UnhideWhenUsed="false" Name="Dark List"/><w:LsdException Locked="false" Priority="71" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Colorful Shading"/><w:LsdException Locked="false" Priority="72" SemiHidden="false"
+
| valign="top" align="left" | [[4.2. Spiegelbepaling]]<br>  
-
UnhideWhenUsed="false" Name="Colorful List"/><w:LsdException Locked="false" Priority="73" SemiHidden="false"
+
| width="45" valign="top" align="left" | Aidsinfo NIH<br>TDM-protocollen
-
UnhideWhenUsed="false" Name="Colorful Grid"/><w:LsdException Locked="false" Priority="60" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Light Shading Accent 1"/><w:LsdException Locked="false" Priority="61" SemiHidden="false"
+
| valign="top" align="left" | [[4.3. Resistentiebepalingen]]<br>  
-
UnhideWhenUsed="false" Name="Light List Accent 1"/><w:LsdException Locked="false" Priority="62" SemiHidden="false"
+
| width="45" valign="top" align="left" | Aidsinfo NIH
-
UnhideWhenUsed="false" Name="Light Grid Accent 1"/><w:LsdException Locked="false" Priority="63" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/><w:LsdException Locked="false" Priority="64" SemiHidden="false"
+
| valign="top" align="left" | '''[[Hoofdstuk 5. Diagnostiek en behandeling primaire hiv-infectie|Hoofdstuk 5. Diagnostiek en behandeling primaire hiv-infectie]]<br>'''  
-
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/><w:LsdException Locked="false" Priority="65" SemiHidden="false"
+
| width="45" valign="top" align="left" | Aidsinfo NIH
-
UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/><w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/><w:LsdException Locked="false" Priority="34" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/><w:LsdException Locked="false" Priority="29" SemiHidden="false"
+
| valign="top" align="left" | '''[[Hoofdstuk 7. Preventie van moeder-kind overdracht: zwangerschap, bevalling en neonatale periode]]<br>'''  
-
UnhideWhenUsed="false" QFormat="true" Name="Quote"/><w:LsdException Locked="false" Priority="30" SemiHidden="false"
+
| width="45" valign="top" align="left" | Aidsinfo NIH Perinatal<br> Landelijk hiv expositie protocol neonaten
-
UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/><w:LsdException Locked="false" Priority="66" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/><w:LsdException Locked="false" Priority="67" SemiHidden="false"
+
| valign="top" align="left" | '''[[Hoofdstuk 8. HIV-2 bij volwassenen: Behandeling en monitoring]]<br>'''  
-
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/><w:LsdException Locked="false" Priority="68" SemiHidden="false"
+
| width="45" valign="top" align="left" | Aidsinfo NIH
-
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/><w:LsdException Locked="false" Priority="69" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/><w:LsdException Locked="false" Priority="70" SemiHidden="false"
+
| valign="top" align="left" | '''[[Hoofdstuk 9. Bijzondere omstandigheden]]'''  
-
UnhideWhenUsed="false" Name="Dark List Accent 1"/><w:LsdException Locked="false" Priority="71" SemiHidden="false"
+
| width="45" valign="top" align="left" |  
-
UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/><w:LsdException Locked="false" Priority="72" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Colorful List Accent 1"/><w:LsdException Locked="false" Priority="73" SemiHidden="false"
+
| valign="top" align="left" | [[9.5. Adviezen m.b.t. gebruik anti-hiv middelen door de sonde]]
-
UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/><w:LsdException Locked="false" Priority="60" SemiHidden="false"
+
| width="45" valign="top" align="left" | EACS
-
UnhideWhenUsed="false" Name="Light Shading Accent 2"/><w:LsdException Locked="false" Priority="61" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Light List Accent 2"/><w:LsdException Locked="false" Priority="62" SemiHidden="false"
+
| valign="top" align="left" | [[9.6. Doseringen bij gestoorde leverfunctie]]
-
UnhideWhenUsed="false" Name="Light Grid Accent 2"/><w:LsdException Locked="false" Priority="63" SemiHidden="false"
+
| width="45" valign="top" align="left" | EACS
-
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/><w:LsdException Locked="false" Priority="64" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/><w:LsdException Locked="false" Priority="65" SemiHidden="false"
+
| valign="top" align="left" | [[9.7. Doseringen bij gestoorde nierfunctie]]
-
UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/><w:LsdException Locked="false" Priority="66" SemiHidden="false"
+
| width="45" valign="top" align="left" | EACS
-
UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/><w:LsdException Locked="false" Priority="67" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/><w:LsdException Locked="false" Priority="68" SemiHidden="false"
+
| valign="top" align="left" | '''[[Hoofdstuk 10. Behandeling van hepatitis B/C-virus coïnfectie bij mensen met hiv-1|Hoofdstuk 10. Behandeling van hepatitis B/C-virus coïnfectie bij mensen met hiv-1]]<br>'''
-
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/><w:LsdException Locked="false" Priority="69" SemiHidden="false"
+
| width="45" valign="top" align="left" | <br>
-
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/><w:LsdException Locked="false" Priority="70" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Dark List Accent 2"/><w:LsdException Locked="false" Priority="71" SemiHidden="false"
+
| valign="top" align="left" | [[10.1. Hepatitis B]]<br>  
-
UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/><w:LsdException Locked="false" Priority="72" SemiHidden="false"
+
| width="45" valign="top" align="left" | Aidsinfo NIH<br>EACS
-
UnhideWhenUsed="false" Name="Colorful List Accent 2"/><w:LsdException Locked="false" Priority="73" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/><w:LsdException Locked="false" Priority="60" SemiHidden="false"
+
| valign="top" align="left" | [[10.2. Hepatitis C|10.2. Hepatitis C]]
-
UnhideWhenUsed="false" Name="Light Shading Accent 3"/><w:LsdException Locked="false" Priority="61" SemiHidden="false"
+
| width="45" valign="top" align="left" | HCV richtsnoer
-
UnhideWhenUsed="false" Name="Light List Accent 3"/><w:LsdException Locked="false" Priority="62" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Light Grid Accent 3"/><w:LsdException Locked="false" Priority="63" SemiHidden="false"
+
| valign="top" align="left" | [[10.3. HCC surveillance|10.3. HCC surveillance]]
-
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/><w:LsdException Locked="false" Priority="64" SemiHidden="false"
+
| width="45" valign="top" align="left" | HBV richtsnoer
-
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/><w:LsdException Locked="false" Priority="65" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/><w:LsdException Locked="false" Priority="66" SemiHidden="false"
+
| valign="top" align="left" | '''[[Hoofdstuk 11. Behandeling van tuberculose bij mensen met een hiv-infectie|Hoofdstuk 11. Behandeling van tuberculose bij mensen met een hiv-infectie]]<br>'''  
-
UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/><w:LsdException Locked="false" Priority="67" SemiHidden="false"
+
| width="45" valign="top" align="left" | KNCV
-
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/><w:LsdException Locked="false" Priority="68" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/><w:LsdException Locked="false" Priority="69" SemiHidden="false"
+
| valign="top" align="left" | '''[[Hoofdstuk 12. Comorbiditeit en bijwerkingen]]<br>'''
-
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/><w:LsdException Locked="false" Priority="70" SemiHidden="false"
+
| width="45" valign="top" align="left" | EACS<br>
-
UnhideWhenUsed="false" Name="Dark List Accent 3"/><w:LsdException Locked="false" Priority="71" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/><w:LsdException Locked="false" Priority="72" SemiHidden="false"
+
| valign="top" align="left" | '''[[Hoofdstuk 13. Screening van mensen met hiv op anogenitale maligniteiten|Hoofdstuk 13. Screening van mensen met hiv op anogenitale maligniteiten]] <br>'''  
-
UnhideWhenUsed="false" Name="Colorful List Accent 3"/><w:LsdException Locked="false" Priority="73" SemiHidden="false"
+
| width="45" valign="top" align="left" | Aidsinfo NIH
-
UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/><w:LsdException Locked="false" Priority="60" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Light Shading Accent 4"/><w:LsdException Locked="false" Priority="61" SemiHidden="false"
+
| valign="top" align="left" | [[Hoofdstuk 15. Profylaxe en behandeling van opportunistische infectie|'''Hoofdstuk 15. Profylaxe en behandeling van opportunistische infectie''']]
-
UnhideWhenUsed="false" Name="Light List Accent 4"/><w:LsdException Locked="false" Priority="62" SemiHidden="false"
+
| width="45" valign="top" align="left" | Aidsinfo NIH<br>Nationale Antibioticaboekje<br>SWAB richtlijnen
-
UnhideWhenUsed="false" Name="Light Grid Accent 4"/><w:LsdException Locked="false" Priority="63" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/><w:LsdException Locked="false" Priority="64" SemiHidden="false"
+
| valign="top" align="left" | '''[[Hoofdstuk 16. Transmissiereductie (PEP)|Hoofdstuk 16. Transmissiemanagement]]<br>'''  
-
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/><w:LsdException Locked="false" Priority="65" SemiHidden="false"
+
| width="45" valign="top" align="left" | <br>
-
UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/><w:LsdException Locked="false" Priority="66" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/><w:LsdException Locked="false" Priority="67" SemiHidden="false"
+
| valign="top" align="left" | [[16.1. Prikaccidenten]]<br>  
-
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/><w:LsdException Locked="false" Priority="68" SemiHidden="false"
+
| width="45" valign="top" align="left" | LCI
-
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/><w:LsdException Locked="false" Priority="69" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/><w:LsdException Locked="false" Priority="70" SemiHidden="false"
+
| valign="top" align="left" | [[16.2. Seksaccidenten]]<br>  
-
UnhideWhenUsed="false" Name="Dark List Accent 4"/><w:LsdException Locked="false" Priority="71" SemiHidden="false"
+
| width="45" valign="top" align="left" | LCI/RIVM
-
UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/><w:LsdException Locked="false" Priority="72" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Colorful List Accent 4"/><w:LsdException Locked="false" Priority="73" SemiHidden="false"
+
| valign="top" align="left" | '''[[Hoofdstuk 17. Vaccinatiebeleid]]<br>'''  
-
UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/><w:LsdException Locked="false" Priority="60" SemiHidden="false"
+
| width="45" valign="top" align="left" | <br>
-
UnhideWhenUsed="false" Name="Light Shading Accent 5"/><w:LsdException Locked="false" Priority="61" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Light List Accent 5"/><w:LsdException Locked="false" Priority="62" SemiHidden="false"
+
| valign="top" align="left" | [[17.2. Vaccinatie tegen influenza]] <br>  
-
UnhideWhenUsed="false" Name="Light Grid Accent 5"/><w:LsdException Locked="false" Priority="63" SemiHidden="false"
+
| width="45" valign="top" align="left" | RIVM<br>NHG
-
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/><w:LsdException Locked="false" Priority="64" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/><w:LsdException Locked="false" Priority="65" SemiHidden="false"
+
| valign="top" align="left" | [[17.4. Vaccinaties tegen Hepatitis A en B]]<br>  
-
UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/><w:LsdException Locked="false" Priority="66" SemiHidden="false"
+
| width="45" valign="top" align="left" | RIVM
-
UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/><w:LsdException Locked="false" Priority="67" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/><w:LsdException Locked="false" Priority="68" SemiHidden="false"
+
| valign="top" align="left" | [https://richtlijnhiv.nvhb.nl/index.php/Addendum:%C2%A0SOA-richtlijn '''Addendum:''' SOA-richtlijn]
-
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/><w:LsdException Locked="false" Priority="69" SemiHidden="false"
+
| width="45" valign="top" align="left" | SOA richtlijn
-
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/><w:LsdException Locked="false" Priority="70" SemiHidden="false"
+
|-
-
UnhideWhenUsed="false" Name="Dark List Accent 5"/><w:LsdException Locked="false" Priority="71" SemiHidden="false"
+
| valign="top" align="left" | [http://richtlijnhiv.nvhb.nl/images/2/22/PrEP-richtlijn-Nederland-8-september-2016-met-logos.pdf '''Addendum:'''&nbsp;Pre-exposure profylaxe (PrEP) richtlijn]
-
UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/><w:LsdException Locked="false" Priority="72" SemiHidden="false"
+
| width="45" valign="top" align="left" | PrEP-richtlijn
-
UnhideWhenUsed="false" Name="Colorful List Accent 5"/><w:LsdException Locked="false" Priority="73" SemiHidden="false"
+
|}
-
UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/><w:LsdException Locked="false" Priority="60" SemiHidden="false"
+
-
UnhideWhenUsed="false" Name="Light Shading Accent 6"/><w:LsdException Locked="false" Priority="61" SemiHidden="false"
+
-
UnhideWhenUsed="false" Name="Light List Accent 6"/><w:LsdException Locked="false" Priority="62" SemiHidden="false"
+
-
UnhideWhenUsed="false" Name="Light Grid Accent 6"/><w:LsdException Locked="false" Priority="63" SemiHidden="false"
+
-
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/><w:LsdException Locked="false" Priority="64" SemiHidden="false"
+
-
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/><w:LsdException Locked="false" Priority="65" SemiHidden="false"
+
-
UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/><w:LsdException Locked="false" Priority="66" SemiHidden="false"
+
-
UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/><w:LsdException Locked="false" Priority="67" SemiHidden="false"
+
-
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/><w:LsdException Locked="false" Priority="68" SemiHidden="false"
+
-
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/><w:LsdException Locked="false" Priority="69" SemiHidden="false"
+
-
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/><w:LsdException Locked="false" Priority="70" SemiHidden="false"
+
-
UnhideWhenUsed="false" Name="Dark List Accent 6"/><w:LsdException Locked="false" Priority="71" SemiHidden="false"
+
-
UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/><w:LsdException Locked="false" Priority="72" SemiHidden="false"
+
-
UnhideWhenUsed="false" Name="Colorful List Accent 6"/><w:LsdException Locked="false" Priority="73" SemiHidden="false"
+
-
UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/><w:LsdException Locked="false" Priority="19" SemiHidden="false"
+
-
UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/><w:LsdException Locked="false" Priority="21" SemiHidden="false"
+
-
UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/><w:LsdException Locked="false" Priority="31" SemiHidden="false"
+
-
UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/><w:LsdException Locked="false" Priority="32" SemiHidden="false"
+
-
UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/><w:LsdException Locked="false" Priority="33" SemiHidden="false"
+
-
UnhideWhenUsed="false" QFormat="true" Name="Book Title"/><w:LsdException Locked="false" Priority="37" Name="Bibliography"/><w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/></w:LatentStyles></xml><&#33;[endif]--><style><&#33;--
+
-
/* Font Definitions */
+
-
@font-face
+
-
{font-family:"Cambria Math";
+
-
panose-1:2 4 5 3 5 4 6 3 2 4;
+
-
mso-font-charset:1;
+
-
mso-generic-font-family:roman;
+
-
mso-font-format:other;
+
-
mso-font-pitch:variable;
+
-
mso-font-signature:0 0 0 0 0 0;}
+
-
@font-face
+
-
{font-family:Calibri;
+
-
panose-1:2 15 5 2 2 2 4 3 2 4;
+
-
mso-font-charset:0;
+
-
mso-generic-font-family:swiss;
+
-
mso-font-pitch:variable;
+
-
mso-font-signature:-520092929 1073786111 9 0 415 0;}
+
-
/* Style Definitions */
+
-
p.MsoNormal, li.MsoNormal, div.MsoNormal
+
-
{mso-style-unhide:no;
+
-
mso-style-qformat:yes;
+
-
mso-style-parent:"";
+
-
margin-top:0cm;
+
-
margin-right:0cm;
+
-
margin-bottom:10.0pt;
+
-
margin-left:0cm;
+
-
line-height:115%;
+
-
mso-pagination:widow-orphan;
+
-
font-size:11.0pt;
+
-
font-family:"Calibri","sans-serif";
+
-
mso-ascii-font-family:Calibri;
+
-
mso-ascii-theme-font:minor-latin;
+
-
mso-fareast-font-family:Calibri;
+
-
mso-fareast-theme-font:minor-latin;
+
-
mso-hansi-font-family:Calibri;
+
-
mso-hansi-theme-font:minor-latin;
+
-
mso-bidi-font-family:"Times New Roman";
+
-
mso-bidi-theme-font:minor-bidi;
+
-
mso-fareast-language:EN-US;}
+
-
a:link, span.MsoHyperlink
+
-
{mso-style-noshow:yes;
+
-
mso-style-priority:99;
+
-
color:blue;
+
-
text-decoration:underline;
+
-
text-underline:single;}
+
-
a:visited, span.MsoHyperlinkFollowed
+
-
{mso-style-noshow:yes;
+
-
mso-style-priority:99;
+
-
color:purple;
+
-
mso-themecolor:followedhyperlink;
+
-
text-decoration:underline;
+
-
text-underline:single;}
+
-
span.SpellE
+
-
{mso-style-name:"";
+
-
mso-spl-e:yes;}
+
-
span.GramE
+
-
{mso-style-name:"";
+
-
mso-gram-e:yes;}
+
-
.MsoChpDefault
+
-
{mso-style-type:export-only;
+
-
mso-default-props:yes;
+
-
mso-ascii-font-family:Calibri;
+
-
mso-ascii-theme-font:minor-latin;
+
-
mso-fareast-font-family:Calibri;
+
-
mso-fareast-theme-font:minor-latin;
+
-
mso-hansi-font-family:Calibri;
+
-
mso-hansi-theme-font:minor-latin;
+
-
mso-bidi-font-family:"Times New Roman";
+
-
mso-bidi-theme-font:minor-bidi;
+
-
mso-fareast-language:EN-US;}
+
-
.MsoPapDefault
+
-
{mso-style-type:export-only;
+
-
margin-bottom:10.0pt;
+
-
line-height:115%;}
+
-
@page WordSection1
+
-
{size:595.3pt 841.9pt;
+
-
margin:70.85pt 70.85pt 70.85pt 70.85pt;
+
-
mso-header-margin:35.4pt;
+
-
mso-footer-margin:35.4pt;
+
-
mso-paper-source:0;}
+
-
div.WordSection1
+
-
{page:WordSection1;}
+
-
--></style><&#33;--[if gte mso 10]><style>
+
-
/* Style Definitions */
+
-
table.MsoNormalTable
+
-
{mso-style-name:Standaardtabel;
+
-
mso-tstyle-rowband-size:0;
+
-
mso-tstyle-colband-size:0;
+
-
mso-style-noshow:yes;
+
-
mso-style-priority:99;
+
-
mso-style-parent:"";
+
-
mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
+
-
mso-para-margin-top:0cm;
+
-
mso-para-margin-right:0cm;
+
-
mso-para-margin-bottom:10.0pt;
+
-
mso-para-margin-left:0cm;
+
-
line-height:115%;
+
-
mso-pagination:widow-orphan;
+
-
font-size:11.0pt;
+
-
font-family:"Calibri","sans-serif";
+
-
mso-ascii-font-family:Calibri;
+
-
mso-ascii-theme-font:minor-latin;
+
-
mso-hansi-font-family:Calibri;
+
-
mso-hansi-theme-font:minor-latin;
+
-
mso-bidi-font-family:"Times New Roman";
+
-
mso-bidi-theme-font:minor-bidi;
+
-
mso-fareast-language:EN-US;}
+
-
table.MsoTableGrid
+
-
{mso-style-name:Tabelraster;
+
-
mso-tstyle-rowband-size:0;
+
-
mso-tstyle-colband-size:0;
+
-
mso-style-priority:59;
+
-
mso-style-unhide:no;
+
-
border:solid windowtext 1.0pt;
+
-
mso-border-alt:solid windowtext .5pt;
+
-
mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
+
-
mso-border-insideh:.5pt solid windowtext;
+
-
mso-border-insidev:.5pt solid windowtext;
+
-
mso-para-margin:0cm;
+
-
mso-para-margin-bottom:.0001pt;
+
-
mso-pagination:widow-orphan;
+
-
font-size:11.0pt;
+
-
font-family:"Calibri","sans-serif";
+
-
mso-ascii-font-family:Calibri;
+
-
mso-ascii-theme-font:minor-latin;
+
-
mso-hansi-font-family:Calibri;
+
-
mso-hansi-theme-font:minor-latin;
+
-
mso-bidi-font-family:"Times New Roman";
+
-
mso-bidi-theme-font:minor-bidi;
+
-
mso-fareast-language:EN-US;}
+
-
</style><&#33;[endif]--><&#33;--[if gte mso 9]><xml><o:shapedefaults v:ext="edit" spidmax="1026"/></xml><&#33;[endif]--><&#33;--[if gte mso 9]><xml><o:shapelayout v:ext="edit"><o:idmap v:ext="edit" data="1"/></o:shapelayout></xml><&#33;[endif]--></head><body lang=NL link=blue vlink=purple style='tab-interval:35.4pt'><div class=WordSection1>
+
-
{| class=MsoTableGrid border=1 cellspacing=0 cellpadding=0 style='border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt; mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt' style='mso-yfti-irow:0;mso-yfti-firstrow:yes'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b>Pagina<o:p></o:p></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border:solid windowtext 1.0pt;  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b>Verwijzing naar andere richtlijnen<o:p></o:p></b></p>
+
-
|-  style='mso-yfti-irow:1'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Richtlijn%20HIV">Hoofdpagina
+
-
(=inhoudsopgave)</a><o:p></o:p></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|-  style='mso-yfti-irow:2'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><o:p>&nbsp;</o:p></b></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|-  style='mso-yfti-irow:3'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%201.%20Achtergrondinformatie%20bij%20de%20ontwikkeling%20en%20herziening%20van%20deze%20richtlijn%20en%20inleiding">Hoofdstuk
+
-
1. Achtergrondinformatie bij de ontwikkeling en herziening van deze richtlijn
+
-
en inleiding</a><o:p></o:p></b></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'>NVHB Richtlijn 2007<o:p></o:p></span></p>
+
-
|-  style='mso-yfti-irow:4'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Procedure%20herziening">Procedure
+
-
herziening</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'>NVHB Richtlijn 2007</p>
+
-
|-  style='mso-yfti-irow:5'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Samenstelling%20kernwerkgroep">Samenstelling
+
-
kernwerkgroep</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:6'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Overzicht%20belangen%20werkgroepleden">Overzicht
+
-
belangen werkgroepleden</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:7'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Definities">Definities</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:8'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'>Geschiedenis per pagina van deze richtlijn (= huidige pagina)</p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:9'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><o:p>&nbsp;</o:p></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|-  style='mso-yfti-irow:10'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%202.%20Therapie%20bij%20volwassenen">Hoofdstuk
+
-
2. Therapie bij volwassenen</a><o:p></o:p></b></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|- style='mso-yfti-irow:11'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/2.1.%20Wanneer%20beginnen?">2.1.
+
-
Wanneer beginnen?</a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:12'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20wanneer%20starten">Onderbouwing
+
-
wanneer starten</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span class=SpellE><span class=GramE>Aidsinfo</span></span> NIH</p>
+
-
|- style='mso-yfti-irow:13'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%202.1">Literatuur
+
-
2.1</a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:14'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/2.2.%20Keuze%20van%20antiretrovirale%20therapie%20bij%20na%C3%AFeve%20volwassen%20pati%C3%ABnten">2.2.
+
-
Keuze van antiretrovirale therapie bij naïeve volwassen patiënten</a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span class=SpellE><span class=GramE>Aidsinfo</span></span> NIH</p>
+
-
|- style='mso-yfti-irow:15'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%202.2">Literatuur
+
-
2.2</a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:16'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/2.3.%20Tijdelijk%20onderbreken%20van%20HAART">2.3.
+
-
Tijdelijk onderbreken van HAART</a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span class=SpellE><span class=GramE>Aidsinfo</span></span> NIH</p>
+
-
|- style='mso-yfti-irow:17'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/T%C2%BD%20van%20antiretrovirale%20middelen">T½
+
-
van antiretrovirale middelen</a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:18'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/2.4.%20Richtlijn%20anti-retrovirale%20therapie%20bij%20voorbehandelde%20pati%C3%ABnten">2.4.
+
-
Richtlijn <span class=SpellE>anti-retrovirale</span> therapie bij <span
+
-
class=SpellE>voorbehandelde</span> patiënten</a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span class=SpellE><span class=GramE>Aidsinfo</span></span> NIH</p>
+
-
|- style='mso-yfti-irow:19'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:20'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%203.%20Behandeling%20van%20HIV-1%20infectie%20bij%20kinderen">Hoofdstuk
+
-
3. Behandeling van HIV-1 infectie bij kinderen</a><o:p></o:p></b></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span class=SpellE><span style='mso-bidi-font-weight:bold'>Penta</span></span><span
+
-
style='mso-bidi-font-weight:bold'><o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span class=SpellE><span class=GramE><span style='mso-bidi-font-weight:
+
-
bold'>Aidsinfo</span></span></span><span style='mso-bidi-font-weight:bold'>
+
-
NIH<o:p></o:p></span></p>
+
-
|- style='mso-yfti-irow:21'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><o:p>&nbsp;</o:p></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|-  style='mso-yfti-irow:22'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%204.%20Monitoring">Hoofdstuk
+
-
4. Monitoring</a><o:p></o:p></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|-  style='mso-yfti-irow:23'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/4.1.%20Controles%20HIV-pati%C3%ABnten%20%28polikliniek%29">4.1.
+
-
Controles HIV-patiënten (polikliniek)</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:24'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Bij%20eerste%20consult%20bij%20HIV-seropositieve%20pati%C3%ABnt%20%28polikliniek%29">Bij
+
-
eerste consult bij <span class=SpellE>HIV-seropositieve</span> patiënt
+
-
(polikliniek)</a><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Bij%20instellen%20op%20antiretrovirale%20therapie%20%28polikliniek%29"
+
-
_fcknotitle=true
+
-
_fcksavedurl="Bij instellen op antiretrovirale therapie (polikliniek)">Bij
+
-
instellen op antiretrovirale therapie (polikliniek)</a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|- style='mso-yfti-irow:25'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Eerste%20controle%20na%20instellen%20op%20anti-retrovirale%20therapie%204-6%20weken%20na%20start%20%28polikliniek%29">Eerste
+
-
controle na instellen op <span class=SpellE>anti-retrovirale</span> therapie
+
-
4-6 weken na start (polikliniek)</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:26'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Controle%20van%20pati%C3%ABnten%20op%20antiretrovirale%20therapie%20%28polikliniek%29">Controle
+
-
van patiënten op antiretrovirale therapie (polikliniek)</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:27'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Controle%20van%20pati%C3%ABnten%20zonder%20antiretrovirale%20therapie%20%28polikliniek%29">Controle
+
-
van patiënten zonder antiretrovirale therapie (polikliniek)</a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:28'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/4.2.%20Spiegelbepaling">4.2.
+
-
Spiegelbepaling</a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|- style='mso-yfti-irow:29'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/4.3.%20Resistentiebepalingen">4.3.
+
-
Resistentiebepalingen</a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|- style='mso-yfti-irow:30'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><o:p>&nbsp;</o:p></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|-  style='mso-yfti-irow:31'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%205.%20Diagnostiek%20en%20behandeling%20primaire%20HIV-infectie">Hoofdstuk
+
-
5. Diagnostiek en behandeling primaire <span class=SpellE>HIV-infectie</span></a><o:p></o:p></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span class=SpellE><span class=GramE><span style='mso-bidi-font-weight:
+
-
bold'>Aidsinfo</span></span></span><span style='mso-bidi-font-weight:bold'>
+
-
NIH<o:p></o:p></span></p>
+
-
|-  style='mso-yfti-irow:32'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><o:p>&nbsp;</o:p></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|-  style='mso-yfti-irow:33'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%206.%20Therapietrouw%20bevorderende%20maatregelen">Hoofdstuk
+
-
6. Therapietrouw bevorderende maatregelen</a><o:p></o:p></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|-  style='mso-yfti-irow:34'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/6.1.%20Therapietrouw%20be%C3%AFnvloedende%20factoren">6.1.
+
-
Therapietrouw beïnvloedende factoren</a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|- style='mso-yfti-irow:35'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%206.1">Literatuur
+
-
6.1</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:36'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/6.2.%20Therapietrouw%20bevorderende%20interventies">6.2.
+
-
Therapietrouw bevorderende interventies</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:37'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20therapietrouw%20bevorderende%20interventies">Onderbouwing
+
-
therapietrouw bevorderende interventies</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:38'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%206.2">Literatuur
+
-
6.2</a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:39'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><o:p>&nbsp;</o:p></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|-  style='mso-yfti-irow:40'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%207.%20Preventie%20van%20moeder-kind%20overdracht:%20zwangerschap,%20bevalling%20en%20neonatale%20periode">Hoofdstuk
+
-
7. Preventie van moeder-kind overdracht: zwangerschap, bevalling en neonatale
+
-
periode</a><o:p></o:p></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span class=SpellE><span class=GramE><span style='mso-bidi-font-weight:
+
-
bold'>Aidsinfo</span></span></span><span style='mso-bidi-font-weight:bold'>
+
-
NIH Perinatal<o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'>NVHB Richtlijn 2007<o:p></o:p></span></p>
+
-
|-  style='mso-yfti-irow:41'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%207">Literatuur
+
-
7</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|- style='mso-yfti-irow:42'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:43'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%208.%20HIV-2%20bij%20volwassenen:%20Behandeling%20en%20monitoring">Hoofdstuk
+
-
8. HIV-2 bij volwassenen: Behandeling en monitoring</a><o:p></o:p></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span class=SpellE><span class=GramE><span style='mso-bidi-font-weight:
+
-
bold'>Aidsinfo</span></span></span><span style='mso-bidi-font-weight:bold'>
+
-
NIH<o:p></o:p></span></p>
+
-
|-  style='mso-yfti-irow:44'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%208">Literatuur
+
-
8</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|- style='mso-yfti-irow:45'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><o:p>&nbsp;</o:p></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|-  style='mso-yfti-irow:46'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%209.%20Bijzondere%20omstandigheden">Hoofdstuk
+
-
9. Bijzondere omstandigheden</a><o:p></o:p></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|-  style='mso-yfti-irow:47'
+
-
width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.1.%20Adviezen%20m.b.t.%20inname%20van%20anti-HIV%20middelen%20na%20braken">9.1.
+
-
Adviezen m.b.t. inname van anti-HIV middelen na braken</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|- style='mso-yfti-irow:48'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.2.%20Adviezen%20m.b.t.%20inname%20van%20anti-HIV%20middelen%20bij%20vergeten%20van%20slikmoment">9.2.
+
-
Adviezen m.b.t. inname van anti-HIV middelen bij vergeten van slikmoment</a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:49'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.3.%20Marge%20tussen%20twee%20innames">9.3.
+
-
Marge tussen twee innames</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|- style='mso-yfti-irow:50'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.4.%20Inname%20medicatie%20bij%20overschrijden%20tijdzones">9.4.
+
-
Inname medicatie bij overschrijden tijdzones</a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:51'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.5.%20Adviezen%20m.b.t.%20gebruik%20anti-HIV%20middelen%20door%20de%20sonde">9.5.
+
-
Adviezen m.b.t. gebruik anti-HIV middelen door de sonde</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|- style='mso-yfti-irow:52'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.6.%20Doseringen%20bij%20gestoorde%20lever-%20en%20nierfunctie">9.6.
+
-
Doseringen bij gestoorde lever- en nierfunctie</a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|- style='mso-yfti-irow:53'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><o:p>&nbsp;</o:p></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|-  style='mso-yfti-irow:54'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2010.%20Behandeling%20van%20hepatitis%20B/C-virus%20co%C3%AFnfectie%20bij%20HIV-1%20positieve%20pati%C3%ABnten">Hoofdstuk
+
-
10. Behandeling van hepatitis B/C-virus <span class=SpellE>coïnfectie</span>
+
-
bij HIV-1 positieve patiënten</a><o:p></o:p></b></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|- style='mso-yfti-irow:55'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/10.1.%20Hepatitis%20B"><span
+
-
lang=EN-US style='mso-ansi-language:EN-US'>10.1. Hepatitis B</span></a><span
+
-
lang=EN-US style='mso-ansi-language:EN-US'><o:p></o:p></span></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'>EACS</p>
+
-
|- style='mso-yfti-irow:56'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/10.2.%20Hepatitis%20C%C2%A0%28acuut%29"><span
+
-
lang=EN-US style='mso-ansi-language:EN-US'>10.2. Hepatitis C&nbsp;(<span
+
-
class=SpellE>acuut</span>)</span></a><span lang=EN-US style='mso-ansi-language:
+
-
EN-US'><o:p></o:p></span></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'>NL aanbevelingen</p><p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'>NEAT</p>
+
-
|-  style='mso-yfti-irow:57'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Levels%20of%20evidence"><span
+
-
lang=EN-US style='mso-ansi-language:EN-US'>Levels of evidence</span></a><span
+
-
lang=EN-US style='mso-ansi-language:EN-US'><o:p></o:p></span></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|- style='mso-yfti-irow:58'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2010.2">Literatuur
+
-
10.2</a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:59'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/10.3.%20Hepatitis%20C%C2%A0%28chronisch%29">10.3.
+
-
Hepatitis C&nbsp;(chronisch)</a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'>EACS</p>
+
-
|- style='mso-yfti-irow:60'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:61'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2011.%20Behandeling%20van%20tuberculose%20bij%20pati%C3%ABnten%20met%20een%20HIV-infectie">Hoofdstuk
+
-
11. Behandeling van tuberculose bij patiënten met een HIV-<span class=SpellE>infectie</span></a><o:p></o:p></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'>CBO Tuberculose-HIV<o:p></o:p></span></p>
+
-
|-  style='mso-yfti-irow:62'
+
-
width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2011">Literatuur
+
-
11</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|- style='mso-yfti-irow:63'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:64'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2012.%20Comorbiditeit%20en%20bijwerkingen">Hoofdstuk
+
-
12. Comorbiditeit en bijwerkingen</a><o:p></o:p></b></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'>EACS<o:p></o:p></span></p>
+
-
|- style='mso-yfti-irow:65'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><o:p>&nbsp;</o:p></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|-  style='mso-yfti-irow:66'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2013.%20Screening%20van%20HIV-pati%C3%ABnten%20op%20anogenitale%20maligniteiten">Hoofdstuk
+
-
13. Screening van HIV-patiënten op anogenitale maligniteiten</a><o:p></o:p></b></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|-  style='mso-yfti-irow:67'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20screening%20van%20HIV-pati%C3%ABnten%20op%20anogenitale%20maligniteiten">Onderbouwing
+
-
screening van HIV-patiënten op anogenitale maligniteiten</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:68'
+
-
width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2013">Literatuur
+
-
13</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|- style='mso-yfti-irow:69'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><o:p>&nbsp;</o:p></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|-  style='mso-yfti-irow:70'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2014.%20Interacties">Hoofdstuk
+
-
14. Interacties</a><o:p></o:p></b></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|-  style='mso-yfti-irow:71'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><o:p>&nbsp;</o:p></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|-  style='mso-yfti-irow:72'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2015.%20Profylaxe%20en%20behandeling%20van%20opportunistische%20infectie">Hoofdstuk
+
-
15. Profylaxe en behandeling van opportunistische infectie</a><o:p></o:p></b></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'>CDC<o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span class=GramE><span style='mso-bidi-font-weight:bold'>Nationale</span></span><span
+
-
style='mso-bidi-font-weight:bold'> antibioticaboekje<o:p></o:p></span></p>
+
-
|- style='mso-yfti-irow:73'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:74'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'>Hoofdstuk 16. Post Exposure Profylaxe na prikaccident en onveilig <span
+
-
class=SpellE>sexueel</span> contact</p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:75'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2016.%20Transmissiereductie%20%28PEP%29">Hoofdstuk
+
-
16. <span class=GramE>Transmissiereductie</span> (PEP)</a><o:p></o:p></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|- style='mso-yfti-irow:76'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/16.1.%20Prikaccidenten">16.1.
+
-
Prikaccidenten</a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'>LCI</p>
+
-
|- style='mso-yfti-irow:77'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/16.2.%20Seksaccidenten">16.2.
+
-
Seksaccidenten</a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'>LCI/RIVM</p>
+
-
|- style='mso-yfti-irow:78'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><o:p>&nbsp;</o:p></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|-  style='mso-yfti-irow:79'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2017.%20Vaccinatiebeleid">Hoofdstuk
+
-
17. Vaccinatiebeleid</a><o:p></o:p></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|-  style='mso-yfti-irow:80'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.1.%20Vaccinaties%20bij%20HIV-ge%C3%AFnfecteerde%20kinderen">17.1.
+
-
Vaccinaties bij <span class=SpellE>HIV-geïnfecteerde</span> kinderen</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'>CDC</p>
+
-
|- style='mso-yfti-irow:81'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.2.%20Vaccinatie%20tegen%20influenza">17.2.
+
-
Vaccinatie tegen influenza</a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'>NHG Standaard</p>
+
-
|- style='mso-yfti-irow:82'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20Vaccinatie%20tegen%20influenza">Onderbouwing
+
-
Vaccinatie tegen influenza</a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:83'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2017.2">Literatuur
+
-
17.2</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|- style='mso-yfti-irow:84'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.3.%20Vaccinatie%20tegen%20infecties%20met%20Streptococcus%20pneumoniae%20%28Pneumokokken%29">17.3.
+
-
Vaccinatie tegen infecties met Streptococcus pneumoniae (Pneumokokken)</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:85'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20Vaccinatie%20tegen%20infecties%20met%20Streptococcus%20pneumoniae%20%28Pneumokokken%29%20%28Pneumokokken%29">Onderbouwing
+
-
Vaccinatie tegen infecties met Streptococcus pneumoniae (Pneumokokken)
+
-
(Pneumokokken)</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:86'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2017.3">Literatuur
+
-
17.3</a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:87'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.4.%20Vaccinaties%20tegen%20Hepatitis%20A%20en%20B">17.4.
+
-
Vaccinaties tegen Hepatitis A en B</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|- style='mso-yfti-irow:88'
+
-
| width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.5.%20Vaccinatie%20bij%20HIV-ge%C3%AFnfecteerde%20reizigers">17.5.
+
-
Vaccinatie bij <span class=SpellE>HIV-geïnfecteerde</span><span
+
-
class=SpellE>reizigers</span></a></p>
+
-
| width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'>LCR</p><p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'>CDC</p>
+
-
|-  style='mso-yfti-irow:89'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Bureau%27s%20voor%20reizigersadvisering"><span
+
-
class=SpellE>Bureau's</span> voor reizigersadvisering</a></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><o:p>&nbsp;</o:p></p>
+
-
|-  style='mso-yfti-irow:90'
+
-
|  width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><o:p>&nbsp;</o:p></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|-  style='mso-yfti-irow:91;mso-yfti-lastrow:yes'
+
-
width=350 valign=top style='width:262.5pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><b><a
+
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2018.%20Kostenoverzicht%20antiretrovirale%20middelen">Hoofdstuk
+
-
18. Kostenoverzicht antiretrovirale middelen</a></b></p>
+
-
|  width=269 valign=top style='width:201.9pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt' | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
+
-
normal'><span style='mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>
+
-
|}<p class=MsoNormal><o:p>&nbsp;</o:p></p></div></body></html>
+

Versie op 23 feb 2021 10:12

In onderstaande tabel staan per hoofdstuk/paragraaf verwijzingen naar andere richtlijnen vermeld:

Pagina
Link naar andere richtlijn
Inhoud SOA richtlijn
PrEP richtlijn
Hoofdstuk 2. Therapie bij volwassenen

2.1. Wanneer beginnen?
Aidsinfo NIH
2.2. Keuze van anti-retrovirale therapie bij naïeve volwassenen met hiv
Aidsinfo NIH
2.3. Tijdelijk onderbreken van anti-retrovirale therapie
Aidsinfo NIH
2.4. Richtlijn anti-retrovirale therapie bij voorbehandelde mensen met hiv
Aidsinfo NIH
Hoofdstuk 3. Behandeling van hiv-1 infectie bij kinderen Aidsinfo NIH
Kinderformularium
Hoofdstuk 4. Monitoring
Aidsinfo NIH
4.2. Spiegelbepaling
Aidsinfo NIH
TDM-protocollen
4.3. Resistentiebepalingen
Aidsinfo NIH
Hoofdstuk 5. Diagnostiek en behandeling primaire hiv-infectie
Aidsinfo NIH
Hoofdstuk 7. Preventie van moeder-kind overdracht: zwangerschap, bevalling en neonatale periode
Aidsinfo NIH Perinatal
Landelijk hiv expositie protocol neonaten
Hoofdstuk 8. HIV-2 bij volwassenen: Behandeling en monitoring
Aidsinfo NIH
Hoofdstuk 9. Bijzondere omstandigheden
9.5. Adviezen m.b.t. gebruik anti-hiv middelen door de sonde EACS
9.6. Doseringen bij gestoorde leverfunctie EACS
9.7. Doseringen bij gestoorde nierfunctie EACS
Hoofdstuk 10. Behandeling van hepatitis B/C-virus coïnfectie bij mensen met hiv-1

10.1. Hepatitis B
Aidsinfo NIH
EACS
10.2. Hepatitis C HCV richtsnoer
10.3. HCC surveillance HBV richtsnoer
Hoofdstuk 11. Behandeling van tuberculose bij mensen met een hiv-infectie
KNCV
Hoofdstuk 12. Comorbiditeit en bijwerkingen
EACS
Hoofdstuk 13. Screening van mensen met hiv op anogenitale maligniteiten
Aidsinfo NIH
Hoofdstuk 15. Profylaxe en behandeling van opportunistische infectie Aidsinfo NIH
Nationale Antibioticaboekje
SWAB richtlijnen
Hoofdstuk 16. Transmissiemanagement

16.1. Prikaccidenten
LCI
16.2. Seksaccidenten
LCI/RIVM
Hoofdstuk 17. Vaccinatiebeleid

17.2. Vaccinatie tegen influenza
RIVM
NHG
17.4. Vaccinaties tegen Hepatitis A en B
RIVM
Addendum: SOA-richtlijn SOA richtlijn
Addendum: Pre-exposure profylaxe (PrEP) richtlijn PrEP-richtlijn